Search Results - "импульсивность"

Refine Results
  1. 1

    Source: Izvestia Ural Federal University Journal. Series 1. Issues in Education, Science and Culture; Том 31, № 3 (2025); 163-173
    Известия Уральского федерального университета. Серия 1. Проблемы образования, науки и культуры; Том 31, № 3 (2025); 163-173

    File Description: application/pdf

  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Source: Psychological and Pedagogical Research – Tula Region; 439-443 ; Психолого-педагогические исследования – Тульскому региону; 439-443

    File Description: text/html

    Relation: info:eu-repo/semantics/altIdentifier/isbn/978-5-907965-58-4; https://phsreda.com/e-articles/10729/Action10729-138392.pdf; Rao V., Rosenberg P., Bertrand M. [et al.]. Aggression after traumatic brain injury: prevalence and correlates // J Neuropsychiatry Clin Neurosci. 2009. Vol. 21 (4). Pp. 420–429. DOI:10.1176/appi.neuropsych.21.4.420.; Miller L. Traumatic Brain Injury and Aggression // Journal of Offender Rehabilitation. 1994. Vol. 21 (3). Pp. 91–103. DOI:10.1300/J076V21N03_06.; Franulic A., Horta E., Maturana R., Scherpenisse J. Organic personality disorder after traumatic brain injury: cognitive, anatomic and psychosocial factors // Brain Injury. 2000. №14 (9). Pp. 759–764. DOI:10.1080/026990500120538.; Kim E. Agitation, aggression, and disinhibition syndromes after traumatic brain injury // NeuroRehabilitation. 2002. Vol. 17 (4). Pp. 297–310. DOI:10.3233/NRE-2002–17404.; Wood R., Liossi C. Neuropsychological and neurobehavioral correlates of aggression following traumatic brain injury // The Journal of Neuropsychiatry and Clinical Neurosciences. 2006. Vol. 18 (3). Pp. 333–341. DOI:10.1176/JNP.2006.18.3.333.; Wood R., Thomas R. Impulsive and episodic disorders of aggressive behaviour following traumatic brain injury // Brain Injury. 2013. Vol. 27 (3). Pp. 253–261. DOI:10.3109/02699052.2012.743181.; Mosti, C., Coccaro, E. Mild traumatic brain injury and aggression, impulsivity, and history of other- and self-directed aggression // The Journal of Neuropsychiatry and Clinical Neurosciences. 2018. Vol. 30 (3). Pp. 220–227. DOI:10.1176/appi.neuropsych.17070141; Corallo F., Anselmo A., Palmeri R. [et al.]. The psychometric measures to assess aggressive dimension following traumatic brain injury // Medicine. 2021. Vol. 100. DOI:10.1097/MD.0000000000024648. EDN: CRJFME; Tateno A., Jorge R., Robinson R. Clinical correlates of aggressive behavior after traumatic brain injury // J Neuropsychiatry Clin Neurosci. 2003. Vol. 15 (2). Pp. 155–160. DOI:10.1176/JNP.15.2.155.; Rahmani E., Lemelle T.M., Sharp H. [et al.]. A descriptive analysis of pharmacological management of aggression and/or agitation in patients with traumatic brain injury // Journal of Clinical Pharmacy and Therapeutics. 2022. Vol. 47. Pp. 2083–2090. DOI:10.1111/jcpt.13754. EDN: BNFGGW; Wong T.M. Brain injury and aggression // Neurology. 2011. Vol. 76. Pp. 1032–1033. DOI:10.1212/WNL.0b013e318211c3fd; https://phsreda.com/article/138392/discussion_platform

  10. 10

    Source: Coaching psychology: methodology, theory, practice; 107-110 ; Психология коучинга: методология, теория, практика; 107-110

    File Description: text/html

    Relation: info:eu-repo/semantics/altIdentifier/isbn/978-5-907965-52-2; https://phsreda.com/e-articles/10698/Action10698-127390.pdf; Анастази А. Психологическое тестирование / А. Анастази; пер. с англ. – Кн. 2. – М.: Педагогика, 1982.; Либин А.В. Стиль человека. Психологический анализ / А.В. Либин. – М.: Смысл, 1998. – 310 с.; Левитов Н.Д. О психических состояниях человека/ Н.Д. Левитов. – М.: Просвещение, 1964. – 344 с.; Моросанова В.И. Роль идей в развитии психологии саморегуляции / В.И. Моросанова, Д.А. Ошанина // Д.А. Ошанин и современная психология: к 100-летию со дня рождения Д.А. Ошанина / под общ. ред. В.И. Панова, Н.Л. Мориной. – М.; Обнинск: ИГ-СОЦИН, 2008. – С. 71–84.; Холодная М.А. Когнитивная психология. Когнитивные стили: учебное пособие для вузов / М.А. Холодная. – 3-е изд. – М.: Юрайт, 2024. – 307 с. – ISBN 978-5-534-06304-2 // Образовательная платформа Юрайт: сайт [Электронный ресурс]. – Режим доступа: https//urait.ru/bcode/540734 (дата обращения: 2003.2025).; https://phsreda.com/article/127390/discussion_platform

  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    Source: The Development of Modern Education in the Context of Pedagogical Competenciology; 36-37 ; Развитие современного образования в контексте педагогической (образовательной) компетенциологии; 36-37

    File Description: text/html

    Relation: info:eu-repo/semantics/altIdentifier/isbn/978-5-907830-24-0; https://phsreda.com/e-articles/10582/Action10582-110929.pdf; Баркли Р.А. Дети с вызывающим поведением: клиническое руководство по обследованию ребенка и тренингу родителей / Р.А. Баркли. – М.: Теревинф, 2011. – 272 с.; Заваденко Н.Н. Синдром дефицита внимания с гиперактивностью: диагностика, патогенез, принципы лечения / Н.Н. Заваденко // Вопросы практической педиатрии. – 2012. – №7 (1). – С. 54–62. EDN OYMXFV; Запорожец А.В. Роль дошкольного воспитания в общем процессе всестороннего развития человеческой личности / А.В. Запорожец // Дошкольное воспитание. – 2005. – №9. – С. 66–69.; Пасечник Л.В. Коррекция тревожности и гиперактивности в детском возрасте / Л.В. Пасечник. – М.: Сфера, 2017. – 123 с.; [Электронный ресурс]. – Режим доступа: https://clck.ru/3A9fZn (дата обращения: 05.04.2024).; Взгляды и теории отечественных и зарубежных психологов в исследованиях синдрома дефицита внимания с гиперактивностью [Электронный ресурс]. – Режим доступа: https://clck.ru/3A9fd4 (дата обращения: 05.04.2024).; https://phsreda.com/article/110929/discussion_platform

  16. 16

    Source: Psychological and Pedagogical Research – Tula Region; 294-296 ; Психолого-педагогические исследования – Тульскому региону; 294-296

    File Description: text/html

    Relation: info:eu-repo/semantics/altIdentifier/isbn/978-5-907830-36-3; https://phsreda.com/e-articles/10611/Action10611-111895.pdf; Бельский П.Г. Хулиганство в детском и юношеском возрасте / П.Г. Бельский. – М.: ГУПИН, 1927. – 76 с.; Холл Кэлвин С. Теории личности / Кэлвин С. Холл, Гарднер Линдсей. – М.: КСП+Питер, 1997. – 720 с.; https://phsreda.com/article/111895/discussion_platform

  17. 17
  18. 18

    Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 16, No 3 (2024); 44-51 ; Неврология, нейропсихиатрия, психосоматика; Vol 16, No 3 (2024); 44-51 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2024-3

    File Description: application/pdf

    Relation: https://nnp.ima-press.net/nnp/article/view/2290/1677; Find NL, Terlizzi R, Munksgaard SB, et al; COMOESTAS Consortium. Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study. J Headache Pain. 2015;17:20. doi:10.1186/s10194-016-0612-2. Epub 2016 Mar 8.; Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi:10.1177/0333102417738202; Fischer MA, Jan A. Medication-Overuse Headache. 2023 Aug 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan—.; Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011 Jul;31(9):1015-22. doi:10.1177/0333102411410082. Epub 2011 May 31.; Kebede YT, Mohammed BD, Tamene BA, et al. Medication overuse headache: a review of current evidence and management strategies. Front Pain Res (Lausanne). 2023 Aug 8;4:1194134. doi:10.3389/fpain.2023.1194134; Cevoli S, Sancisi E, Grimaldi D, et al. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache. 2009 Mar;49(3):412-8. doi:10.1111/j.1526-4610.2008.01257.x; Ailani J, Burch RC, Robbins MS; Board of Directors of the American Headache Society. The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache. 2021 Jul;61(7):1021-39. doi:10.1111/head.14153. Epub 2021 Jun 23.; Lau CI, Liu MN, Chen WH, et al. Clinical and biobehavioral perspectives: Is medication overuse headache a behavior of dependence? Prog Brain Res. 2020;255:371-402. doi:10.1016/bs.pbr.2020.05.019. Epub 2020 Jun 19.; Saylor D, Steiner TJ. The Global Burden of Headache. Semin Neurol. 2018 Apr;38(2):182-90. doi:10.1055/s-0038-1646946. Epub 2018 May 23.; He Z, Dong L, Zhang Y, et alJ. Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China. Eur J Neurol. 2015 Aug;22(8):1228-34. doi:10.1111/ene.12732. Epub 2015 May 15.; Togha M, Karimitafti MJ, Ghorbani Z, et al. Characteristics and comorbidities of headache in patients over 50 years of age: a cross-sectional study. BMC Geriatr. 2022 Apr 10;22(1):313. doi:10.1186/s12877-022-03027-1; Hagen K, Linde M, Steiner TJ, et al. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord-Trondelag Health Studies. Pain. 2012 Jan;153(1):56-61. doi:10.1016/j.pain.2011.08.018. Epub 2011 Oct 22.; Westergaard ML, Glumer C, Hansen EH, Jensen RH. Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain. 2014 Oct;155(10):2005-13. doi:10.1016/j.pain.2014.07.002. Epub 2014 Jul 11.; Radat F, Creac'h C, Swendsen JD, et al. Psychiatric comorbidity in the evolution from migraine to medication overuse headache. Cephalalgia. 2005 Jul;25(7):519-22. doi:10.1111/j.1468-2982.2005.00910.x; Zwart JA, Dyb G, Hagen K, et al. Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Health Study. Eur J Neurol. 2003 Mar;10(2):147-52. doi:10.1046/j.1468-1331.2003.00551.x; Шагбазян АЭ, Сергеев АВ, Евдокимова ЕМ и др. Роль эмоциональных и поведенческих расстройств в формировании лекарственной зависимости у пациентов с медикаментозно-индуцированной головной болью. Неврология, нейропсихиатрия, психосоматика. 2016;8(3):76-81. doi:10.14412/2074-2711-2016-3-76-81; Головачева ВА, Головачева АА, Фатеева ТГ, Володарская ЕА. «Внутренняя картина болезни» у пациентов с хронической мигренью: когнитивные, эмоциональные и поведенческие аспекты. Неврология, нейропсихиатрия, психосоматика. 2023;15(1):28-35. doi:10.14412/2074-2711-2023-1-28-35; Peres MF, Mercante JP, Guendler VZ, et al. Cephalalgiaphobia: a possible specific phobia of illness. J Headache Pain. 2007 Feb;8(1):56-9. doi:10.1007/s10194-007-0361-3. Epub 2007 Feb 19.; Старикова НЛ. Лекарственно-индуцированная головная боль (обзор литературы и рекомендации для практики). Архивъ внутренней медицины. 2023;13(3):175-80. doi:10.20514/2226-6704-2023-13-3-175-180; Giannini G, Zanigni S, Grimaldi D, et al. Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study. J Headache Pain. 2013 Jun 10;14(1):49. doi:10.1186/1129-237714-49; Klan T, Diezemann-Prossdorf A, Guth AL, et al. Attackenangst bei Migrane: Diagnostik und Behandlung [Fear of migraine attacks: diagnosis and treatment]. Schmerz. 2023 Apr 18:1-8. doi:10.1007/s00482-023-00711-y. Epub ahead of print (In German).; Klepper JE, Sebrow L, Rosen NL, Seng EK. Cogniphobia and neuropsychological functioning in migraine. Neuropsychology. 2022 Jul;36(5):433-42. doi:10.1037/neu0000808. Epub 2022 Apr 7.; Rogers DG, Protti TA, Smitherman TA. Fear, Avoidance, and Disability in Headache Disorders. Curr Pain Headache Rep. 2020 May 29;24(7):33. doi:10.1007/s11916-020-00865-9; Табеева ГР, Филатова ЕГ, Амелин АВ и др. Альтернативные и комплементарные методы лечения мигрени. Неврология, нейропсихиатрия, психосоматика. 2024;16(1):4-15. doi:10.14412/2074-27112024-1-4-15; Клинические рекомендации МЗ РФ по диагностике и лечению мигрени. 2021. Доступно по ссылке: https://cr.minzdrav.gov.ru/schema/295_2?ysclid=lveea72itr947791593; Табеева ГР, Осипова ВВ, Филатова ЕГ и др. Диагностика и лечение лекарственно-индуцированной головной боли: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2022;14(1):4-13. doi:10.14412/2074-27112022-1-4-13; Diener HC, Dodick D, Evers S, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019 Sep;18(9):891-902. doi:10.1016/S1474-4422(19)30146-2. Epub 2019 Jun 4.; Diener HC, Antonaci F, Braschinsky M, et al. European Academy of Neurology guideline on the management of medication-overuse headache. Eur J Neurol. 2020 Jul;27(7):1102-16. doi:10.1111/ene.14268. Epub 2020 May 19.; Grazzi L, Sansone E, Raggi A, et al. Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up. J Headache Pain.2017 Dec;18(1):15. doi:10.1186/s10194-017-0728-z. Epub 2017 Feb 4.; Сергеев АВ, Табеева ГР, Филатова ЕГ и др. Применение новой биологической патогенетической терапии мигрени в клинической практике: консенсус экспертов Российского общества по изучению головной боли. Неврология, нейропсихиатрия, психосоматика. 2022;14(5):109-16. doi:10.14412/2074-2711-2022-5-109-116; Chiang CC, Schwedt TJ, Wang SJ, Dodick DW. Treatment of medication-overuse headache: A systematic review. Cephalalgia. 2016 Apr;36(4):371-86. doi:10.1177/0333102415593088. Epub 2015 Jun 29.; Boe MG, Thortveit E, Vatne A, Mygland A. Chronic headache with medication overuse: Long-term prognosis after withdrawal therapy. Cephalalgia. 2017 Nov;37(13):1215-21. doi:10.1177/0333102416672493. Epub 2016 Oct 5.; Zidverc-Trajkovic JJ, Pekmezovic T, Jovanovic Z, et al. Long-term predictors of remission in patients treated for medicationoveruse headache at a specialized headache center: A prospective cohort study. Cephalalgia. 2018 Feb;38(2):265-73. doi:10.1177/0333102416683918. Epub 2016 Dec 11.; Basedau H, Ornello R, Matteis E, et al. Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects? Cephalalgia. 2023 Dec;43(12):3331024231218392. doi:10.1177/03331024231218392; Scher AI, Rizzoli PB, Loder EW. Medication overuse headache: An entrenched idea in need of scrutiny. Neurology. 2017 Sep 19;89(12):1296-304. doi:10.1212/WNL.0000000000004371. Epub 2017 Aug 18.

  19. 19

    Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 16, No 1S (2024): Спецвыпуск: Головная боль; 52-58 ; Неврология, нейропсихиатрия, психосоматика; Vol 16, No 1S (2024): Спецвыпуск: Головная боль; 52-58 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2024-1S

    File Description: application/pdf

    Relation: https://nnp.ima-press.net/nnp/article/view/2384/1737; Chen PK, Wang SJ. Medication Overuse and Medication Overuse Headache: Risk Factors, Comorbidities, Associated Burdens and Nonpharmacologic and Pharmacologic Treatment Approaches. Curr Pain Headache Rep. 2019 Jul 26;23(8):60. doi:10.1007/s11916-019-0796-7; Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012 May;19(5):703-11. doi:10.1111/j.1468-1331.2011.03612.x. Epub 2011 Dec 5.; Табеева ГР, Осипова ВВ, Филатова ЕГ и др. Диагностика и лечение лекарственно-индуцированной головной боли: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2022;14(1):4-13. doi:10.14412/2074-2711-2022-1-4-13; Ashina S, Terwindt GM, Steiner TJ, et al. Medication overuse headache. Nat Rev Dis Primers. 2023 Feb 2;9(1):5. doi:10.1038/s41572-022-00415-0; Shimizu T, Sakai F, Miyake H, et al. Disability, quality of life, productivity impairment and employer costs of migraine in the workplace. J Headache Pain. 2021 Apr 21;22(1):29. doi:10.1186/s10194-021-01243-5; Vandenbussche N, Laterza D, Lisicki M, et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain. 2018 Jul 13;19(1):50. doi:10.1186/s10194-018-0875-x; Hagen K, Linde M, Steiner TJ, et al. Risk factors for medication-overuse headache: an 11-year follow-up study. The Nord- Trondelag Health Studies. Pain. 2012 Jan;153(1):56-61. doi:10.1016/j.pain.2011.08.018. Epub 2011 Oct 22.; He Z, Dong L, Zhang Y, et al. Metabolic syndrome in female migraine patients is associated with medication overuse headache: a clinic-based study in China. Eur J Neurol. 2015 Aug;22(8):1228-34. doi:10.1111/ene.12732; Westergaard ML, Glümer C, Hansen EH, Jensen RH. Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain. 2014 Oct;155(10):2005-13. doi:10.1016/j.pain.2014.07.002. Epub 2014 Jul 11.; Straube A, Pfaffenrath V, Ladwig KH, et al. Prevalence of chronic migraine and medication overuse headache in Germany – the German DMKG headache study. Cephalalgia. 2010 Feb;30(2):207-13. doi:10.1111/j.1468-2982.2009.01906.x; Ashina M, Terwindt GM, Al-Karagholi MA, et al. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet. 2021 Apr 17;397(10283):1496-504. doi:10.1016/S0140-6736(20)32162-0. Epub 2021 Mar 25.; Recober A, Goadsby PJ. Calcitonin gene-related peptide: A molecular link between obesity and migraine? Drug News Perspect. 2010 Mar;23(2):112-7. doi:10.1358/dnp.2010.23.2.1475909; Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011 Jul;31(9):1015-22. doi:10.1177/0333102411410082. Epub 2011 May 31.; Kebede YT, Mohammed BD, Tamene BA, et al. Medication overuse headache: a review of current evidence and management strategies. Front Pain Res (Lausanne). 2023 Aug 8;4:1194134. doi:10.3389/fpain.2023.1194134; Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008 Sep;48(8):1157-68. doi:10.1111/j.1526-4610.2008.01217.x; Burch RC, Buse DC, Lipton RB. Migraine: Epidemiology, Burden, and Comorbidity. Neurol Clin. 2019 Nov;37(4):631-49. doi:10.1016/j.ncl.2019.06.001. Epub 2019 Aug 27.; Lau CI, Liu MN, Chen WH, et al. Clinical and biobehavioral perspectives: Is medication overuse headache a behavior of dependence? Prog Brain Res. 2020;255:371-402. doi:10.1016/bs.pbr.2020.05.019. Epub 2020 Jun 19.; Florencio LL, de Oliveira AS, Carvalho GF, et al. Association Between Severity of Temporomandibular Disorders and the Frequency of Headache Attacks in Women With Migraine: A Cross-Sectional Study. J Manipulative Physiol Ther. 2017 May;40(4):250-4. doi:10.1016/j.jmpt.2017.02.006. Epub 2017 Apr 6.; Bendtsen L, Munksgaard S, Tassorelli C, et al. COMOESTAS Consortium. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2014 May;34(6):426-33. doi:10.1177/0333102413515338. Epub 2013 Dec 9.; Park HK, Chu MK, Oh SY, et al; RELEASE investigators. Interim analysis of the Registry for Load and Management of Medication Overuse Headache (RELEASE): A multicenter, comprehensive medication over- use headache registry. Cephalalgia. 2022 May;42(6):455-65. doi:10.1177/03331024211057184. Epub 2021 Nov 17.; Aaseth K, Grande RB, Kvaerner KJ, et al. Prevalence of secondary chronic headaches in a population-based sample of 30–44-year-old persons. The Akershus study of chronic headache. Cephalalgia. 2008 Jul;28(7):705-13. doi:10.1111/j.1468-2982.2008.01577.x. Epub 2008 May 21.; Cupini LM, De Murtas M, Costa C, et al. Obsessive-compulsive disorder and migraine with medication-overuse headache. Headache. 2009 Jul;49(7):1005-13. doi:10.1111/j.1526-4610.2009.01457.x. Epub 2009 Jun 1.; Fuh JL, Wang SJ, Lu SR, Juang KD. Does medication overuse headache represent a behavior of dependence? Pain. 2005 Dec 15;119(1-3):49-55. doi:10.1016/j.pain.2005.09.034. Epub 2005 Nov 17.; Radat F, Lanteri-Minet M. What is the role of dependence-related behavior in medication- overuse headache? Headache. 2010 Nov;50(10):1597-611. doi:10.1111/j.1526-4610.2010.01755.x. Epub 2010 Aug 27.; Hasin DS, O'Brien CP, Auriacombe M, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013 Aug;170(8):834-51. doi:10.1176/appi.ajp.2013.12060782; Radat F, Creac’h C, Guegan-Massardier E, et al. Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria. Headache. 2008 Jul;48(7):1026-36. doi:10.1111/j.1526-4610.2007.00999.x. Epub 2007 Dec 11.; Lake AE 3rd. Medication overuse headache: biobehavioral issues and solutions. Headache. 2006 Oct;46 Suppl 3:S88-97. doi:10.1111/j.1526-4610.2006.00560.x; Robinson TE, Berridge KC. Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3137-46. doi:10.1098/rstb.2008.0093; Cevoli S, Sancisi E, Grimaldi D, et al. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache. 2009 Mar;49(3):412-8. doi:10.1111/j.1526-4610.2008.01257.x; First MB. Diagnostic and statistical manual of mental disorders, 5th edition, and clinical utility. J Nerv Ment Dis. 2013 Sep;201(9):727-9. doi:10.1097/NMD.0b013e3182a2168a; Rosignoli C, Ornello R, Onofri A, et al. Applying a biopsychosocial model to migraine: rationale and clinical implications. J Headache Pain. 2022 Aug 11;23(1):100. doi:10.1186/s10194-022-01471-3; Bigal ME, Sheftell FD, Rapoport AM, et al. MMPI personality profiles in patients with primary chronic daily headache: a case-control study. Neurol Sci. 2003 Oct;24(3):103-10. doi:10.1007/s10072-003-0094-2; Karakurum B, Soylu O, Karatas M, et al. Personality, depression, and anxiety as risk factors for chronic migraine. Int J Neurosci. 2004 Nov;114(11):1391-9. doi:10.1080/00207450490476002; Silberstein SD, Lipton RB, Breslau N. Migraine: association with personality characteristics and psychopathology. Cephalalgia. 1995 Oct;15(5):358-69; discussion 336. doi:10.1046/j.1468-2982.1995.1505358.x; Garramone F, Baiano C, Russo A, et al. Personality profile and depression in migraine: a meta-analysis. Neurol Sci. 2020 Mar;41(3):543-54. doi:10.1007/s10072-019-04174-x. Epub 2019 Dec 12.; Rausa M, Cevoli S, Sancisi E, et al. Personality traits in chronic daily headache patients with and without psychiatric comorbidity: an observational study in a tertiary care headache center. J Headache Pain. 2013 Mar 4;14(1):22. doi:10.1186/1129-2377-14-22; Bottiroli S, Viana M, Sances G, et al. Psychological factors associated with failure of detoxification treatment in chronic headache associated with medication overuse. Cephalalgia. 2016 Dec;36(14):1356-65. doi:10.1177/0333102416631960. Epub 2016 Feb 15.; Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi:10.1177/0333102417738202

  20. 20